CEO Today Africa Awards

SOUTH AFRICA www.ceotodaymagazine.com 62 CEO Today Africa Awards 2018 KOERT PRETORIUS CEO of Mediclinic International ABOUT KOERT PRETORIUS Mr Koert Pretorius joined the Group in 1998 as the regional manager of the central region of Mediclinic’s operations in South Africa, after which he was appointed as the Chief Operating Officer of the Mediclinic Group in 2003. He was appointed as the Chief Executive Officer of Mediclinic Southern Africa in 2008 and served as an executive director of Mediclinic International Limited in 2006 up to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. Qualifications: Mr Pretorius holds a Bachelor’s degree in Accounting Science from the University of the Free State (B.Compt.); and a Master’s degree of Business Leadership from the University of South Africa (MBL). FIRM PROFILE Mediclinic is an international private healthcare services group with its core purpose to deliver value for patients by providing high-quality, cost-effective, integrated healthcare services in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, doctors and funders in each of its markets. Founded in 1983 in South Africa, the Group has expanded significantly over time and currently has operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates, and holds a 29.9% interest in Spire Healthcare Group plc, a LSE-listed and UK-based private healthcare group. Mediclinic comprises 75 hospitals and 28 clinics: Hirslanden operates 17 private acute care facilities and four clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 48 hospitals and two day clinics throughout South Africa and three hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates seven hospitals and 22 clinics with more than 800 inpatient beds in the United Arab Emirates. The Company has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. The Company’s registered office is in London, United Kingdom with the Group management office in Stellenbosch, South Africa. STRATEGIC OVERVIEW The Group’s strategic focus is to deliver high-quality healthcare services and provide an optimal patient experience across the operating divisions in Switzerland, Southern Africa and the Middle East. To this end, Mediclinic continued to invest in its people, clinical facilities and technology during the year. The Group’s growing international scale enables it to unlock further value through promoting collaboration and best practice between its operating divisions and to extract further synergies and cost- efficiencies. Long-term demand for Mediclinic’s services, across its operating divisions, remains robust, underpinned by inter alia ageing population, growing disease burden and technological innovation. However, the increase in demand across the operating divisions is juxtaposed by lower economic growth in some regions and greater competition. In addition, there is an increased focus on the affordability of delivering healthcare which is resulting in changing care delivery models and greater regulatory oversight. The Group is well positioned to continue to drive long-term value for its shareholders with a well-balanced portfolio of global operations in all three attractive healthcare markets. Together with an equity investment, this portfolio provides the Group with a sound platform for sustainable long-term performance. www.mediclinic.com